Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine
about
Neurosteroids and GABA(A) Receptor Interactions: A Focus on StressPregnenolone rescues schizophrenia-like behavior in dopamine transporter knockout mice.Finasteride induced depression: a prospective studyFluvoxamine versus other anti-depressive agents for depressionMedroxyprogesterone acetate antagonizes the effects of estrogen treatment on social and sexual behavior in female macaques.The role of sex steroids in catamenial epilepsy and premenstrual dysphoric disorder: implications for diagnosis and treatmentThe dark side of 5α-reductase inhibitors' therapy: sexual dysfunction, high Gleason grade prostate cancer and depressionBrain 5alpha-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolationIn a mouse model relevant for post-traumatic stress disorder, selective brain steroidogenic stimulants (SBSS) improve behavioral deficits by normalizing allopregnanolone biosynthesis.Neurosteroids' effects and mechanisms for social, cognitive, emotional, and physical functionsInhibition of recombinant L-type voltage-gated calcium channels by positive allosteric modulators of GABAA receptorsNeurosteroids in the context of stress: implications for depressive disordersSelective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymesRole of microsomal retinol/sterol dehydrogenase-like short-chain dehydrogenases/reductases in the oxidation and epimerization of 3alpha-hydroxysteroids in human tissuesNeurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodentsSSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptakeRecent developments in the significance and therapeutic relevance of neuroactive steroids--Introduction to the special issueCortical and subcortical gamma amino acid butyric acid deficits in anxiety and stress disorders: Clinical implicationsPlasticity of GABAA Receptors during Pregnancy and Postpartum Period: From Gene to FunctionThe role of reproductive hormones in postpartum depressionAllopregnanolone as a mediator of affective switching in reproductive mood disordersGABAergic neuroactive steroids: a new frontier in bipolar disorders?Stress, seizures, and hypothalamic-pituitary-adrenal axis targets for the treatment of epilepsyTranslocator protein-mediated pharmacology of cholesterol transport and steroidogenesisInvited review: the evolution of antidepressant mechanismsGABAA receptor-acting neurosteroids: a role in the development and regulation of the stress responseNeurosteroids: endogenous regulators of the GABA(A) receptorBlunted neuroactive steroid and HPA axis responses to stress are associated with reduced sleep quality and negative affect in pregnancy: a pilot studySex differences in anxiety, sensorimotor gating and expression of the alpha4 subunit of the GABAA receptor in the amygdala after progesterone withdrawal.Beyond the HPA Axis: Progesterone-Derived Neuroactive Steroids in Human Stress and EmotionNeuroactive Steroids are Altered in Schizophrenia and Bipolar Disorder: Relevance to Pathophysiology and TherapeuticsAntipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotectionCRH receptor antagonism reverses the effect of social subordination upon central GABAA receptor binding in estradiol-treated ovariectomized female rhesus monkeys.Ganaxolone improves behavioral deficits in a mouse model of post-traumatic stress disorderExpression of GABAA α2-, β1- and ε-receptors are altered significantly in the lateral cerebellum of subjects with schizophrenia, major depression and bipolar disorderThe GABAergic deficit hypothesis of major depressive disorder.Neurosteroids reduce social isolation-induced behavioral deficits: a proposed link with neurosteroid-mediated upregulation of BDNF expression.Manipulation of GABAergic steroids: Sex differences in the effects on alcohol drinking- and withdrawal-related behaviors.Behavioral and neurogenomic transcriptome changes in wild-derived zebrafish with fluoxetine treatmentAltered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants
P2860
Q21129366-085533D1-1920-4DD5-8D74-BE282708B7D8Q21133801-7BC4FD45-4A5C-4DC0-8505-552B37D019AFQ21254638-3789AF3D-330D-47F1-82AB-DF1DB63B216EQ24236814-A6FE0824-538D-458E-A8FB-6B12567C0CB8Q24542881-382EA8FF-3723-4BB1-A0E1-C95BA6B77568Q24561815-007EF433-0761-4219-B60B-629F93C9B96EQ24564068-FC49862D-B015-47C7-A1EE-2BDC30A7870CQ24595197-0D912F45-19FB-4598-B7E0-F1D2FD8E33F0Q24605563-2CA2410B-8491-4C7C-BA8A-313956CDCB0EQ24618586-8C3C2764-BA1C-49A6-84C0-5880AD4B5BDEQ24632514-5A9FEC00-9047-4886-9866-3AD9ADE3C0D0Q24646222-D8B2A769-A26F-4DDB-9B60-F447A9930396Q24648866-48899C16-5784-44FF-ACCB-7246E7ED6F3FQ24649074-A07100A6-5307-4854-B120-E0A604723623Q24656267-3DFD0B88-A931-448E-A975-706EFB44CF62Q24657383-189D812E-EC45-47BE-B2F7-B937116F21C6Q24670760-1FDC082A-77E7-49E8-982F-4862F71A2BA6Q26750907-E5F8CE16-06BC-44D8-BB38-F12CD367DAFEQ26785771-21D5CEEB-97A1-4E8D-9CC5-3EFF72A3C963Q26849873-A76F0C49-4792-4722-94CE-AAE9A9C71214Q26866177-93995611-F62D-4628-8AD3-ECB608868865Q27011690-5BBF5AAA-683F-42BC-9E0B-72AD2F9FB2E9Q27013911-37E27035-FD5F-4014-9B14-FB20CA932E16Q28083751-8E6E517D-B54F-40C1-89A0-185D1FED00C8Q28241221-04C58706-0CCB-4A12-B9D7-BBEA91B14D21Q28241963-A9A8BFA1-CE77-48E3-9B41-2CDB7D7B930EQ28256904-45D1A92E-7129-4A7B-8618-F7761CDD6EDBQ28390344-99DFBE20-AF60-4BEC-9E5F-FC3C70AAD071Q28579679-77F62574-66B4-42D8-AE3C-7703608F6F25Q28729887-305627F2-803B-4A36-BEA8-7FE38296457EQ29011855-B1ADE21B-DF20-4C70-B9D8-C4E6E3AC0A8BQ30386608-4CAD89F4-37C4-4268-A850-02B5FB92DA8DQ30410273-2CC3C182-9099-4D6C-895E-D36C0CA78722Q30428666-0C923426-7DA5-4071-839C-C370431E5D25Q30448885-B00772D1-E59B-4C62-8BAB-37D46478AE0AQ30464954-F333CB6B-3A3B-47DE-A4C3-641A64698AE6Q30467322-962A911B-FC9E-4318-AC8F-3692398DCE10Q30477804-49A159F6-5190-4097-B0BD-214FD28AEADEQ30540157-43F90A34-4836-41CD-BE16-A35030A18DB7Q30887852-1FD86209-AE88-40AC-8A10-8DD7D012600A
P2860
Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine
description
1998 nî lūn-bûn
@nan
1998 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մարտին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Increase in the cerebrospinal ...... ving fluoxetine or fluvoxamine
@ast
Increase in the cerebrospinal ...... ving fluoxetine or fluvoxamine
@en
Increase in the cerebrospinal ...... ving fluoxetine or fluvoxamine
@nl
type
label
Increase in the cerebrospinal ...... ving fluoxetine or fluvoxamine
@ast
Increase in the cerebrospinal ...... ving fluoxetine or fluvoxamine
@en
Increase in the cerebrospinal ...... ving fluoxetine or fluvoxamine
@nl
prefLabel
Increase in the cerebrospinal ...... ving fluoxetine or fluvoxamine
@ast
Increase in the cerebrospinal ...... ving fluoxetine or fluvoxamine
@en
Increase in the cerebrospinal ...... ving fluoxetine or fluvoxamine
@nl
P2093
P2860
P921
P356
P1476
Increase in the cerebrospinal ...... ving fluoxetine or fluvoxamine
@en
P2093
A Guidotti
A Rasmusson
D P Uzunov
P2860
P304
P356
10.1073/PNAS.95.6.3239
P407
P577
1998-03-17T00:00:00Z